TY - JOUR
T1 - Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: A report from the Euro Heart Survey on diabetes and the heart
AU - Novo, Salvatore
AU - Santolaya Rubio, Javier
AU - Coppola, Giuseppe
AU - Desideri, Alessandro
AU - Mantovani, Dario Giuseppe
AU - Rossi, David
AU - Lombardi, Franco
AU - Brandariz Garcia, Josè Angel
AU - Meloni, Maurizio
AU - Martinez, Vito Bruno
PY - 2006
Y1 - 2006
N2 - Aims: Although diabetes is known to be a major contributor to cardiovascular diseases, as well as an independent predictor for adverse outcomes in patients with coronary artery disease (CAD), information on the prognosis of patients with CAD and newly diagnosed diabetes or impaired glucose regulation (IGR) is scarce. The objective of this study was to explore 1-year outcome in relation to different glucometabolic states of patients participating in the Euro Heart Survey on diabetes and the heart. Methods and results: In 4676 out of 4961 patients, information on the relation between 1-year outcome and glucometabolic state, which was based on oral glucose tolerance test (OGTT) or fasting glucose plasma, was available. A normal glucose metabolism was identified in 947 patients, IGR (impaired fasting glucose or impaired glucose tolerance) in 1116 patients, and diabetes in 1877 patients of whom 1425 were previously diagnosed and 452 newly diagnosed. In total, 736 patients could not be classified, as no OGTT or fasting plasma glucose was performed. Previously recognized and newly detected diabetes was associated with an increased risk of 1-year mortality when compared with patients with normal glucose regulation [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.5-3.8 and HR 2.0, 95% CI 1.1-3.6, respectively)]. IGR, however, could not be identified as an independent predictor for 1-year mortality (HR 1.1, 95% CI 0.6-1.9). Conclusion: This study confirmed that patients with CAD and known diabetes are at high risk for mortality and cardiovascular events and demonstrated that patients with newly diagnosed diabetes are at intermediate risk for adverse outcomes. IGR, however, could not be identified as an independent predictor for adverse outcomes during the 1-year follow-up period. © The European Society of Cardiology 2006. All rights reserved.
AB - Aims: Although diabetes is known to be a major contributor to cardiovascular diseases, as well as an independent predictor for adverse outcomes in patients with coronary artery disease (CAD), information on the prognosis of patients with CAD and newly diagnosed diabetes or impaired glucose regulation (IGR) is scarce. The objective of this study was to explore 1-year outcome in relation to different glucometabolic states of patients participating in the Euro Heart Survey on diabetes and the heart. Methods and results: In 4676 out of 4961 patients, information on the relation between 1-year outcome and glucometabolic state, which was based on oral glucose tolerance test (OGTT) or fasting glucose plasma, was available. A normal glucose metabolism was identified in 947 patients, IGR (impaired fasting glucose or impaired glucose tolerance) in 1116 patients, and diabetes in 1877 patients of whom 1425 were previously diagnosed and 452 newly diagnosed. In total, 736 patients could not be classified, as no OGTT or fasting plasma glucose was performed. Previously recognized and newly detected diabetes was associated with an increased risk of 1-year mortality when compared with patients with normal glucose regulation [hazard ratio (HR) 2.4, 95% confidence interval (CI) 1.5-3.8 and HR 2.0, 95% CI 1.1-3.6, respectively)]. IGR, however, could not be identified as an independent predictor for 1-year mortality (HR 1.1, 95% CI 0.6-1.9). Conclusion: This study confirmed that patients with CAD and known diabetes are at high risk for mortality and cardiovascular events and demonstrated that patients with newly diagnosed diabetes are at intermediate risk for adverse outcomes. IGR, however, could not be identified as an independent predictor for adverse outcomes during the 1-year follow-up period. © The European Society of Cardiology 2006. All rights reserved.
KW - Aged
KW - Blood Glucose
KW - Coronary Artery Disease
KW - Coronary artery disease
KW - Diabetes
KW - Diabetic Angiopathies
KW - Euro Heart Survey
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Impaired glucose regulation
KW - Male
KW - Middle Aged
KW - Myocardial Infarction
KW - Prognosis
KW - Stroke
KW - Survival Analysis
KW - Aged
KW - Blood Glucose
KW - Coronary Artery Disease
KW - Coronary artery disease
KW - Diabetes
KW - Diabetic Angiopathies
KW - Euro Heart Survey
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Impaired glucose regulation
KW - Male
KW - Middle Aged
KW - Myocardial Infarction
KW - Prognosis
KW - Stroke
KW - Survival Analysis
UR - http://hdl.handle.net/10447/365114
UR - http://eurheartj.oxfordjournals.org/
M3 - Article
SN - 0195-668X
VL - 27
SP - 2969
EP - 2974
JO - European Heart Journal
JF - European Heart Journal
ER -